Balanced news tone
News Sentiment
ABBOTINDIA sentiment intelligence
Abbott India Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
81/100 classification confidence.
directly relevant articles
high-authority source matches
+4.9% over one week, +3.4% over four weeks, trend inactive, and near fair-value range.
Polycab India Ltd (BOM:542652) Q1 2027 Earnings Call Highlights: Record Revenue and Profit ...
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Polycab India Ltd (BOM:542652) Q1 2027 Earnings Call Highlights: Record Revenue and Profit ...
- Tone
- Positive 83/100
- Event
- Earnings
- Published
- 16 Jul 2026 19:00
- Source
- GuruFocus.com
Abbott India - Positive Breakout: These 11 stocks cross above their 200 DMAs
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 16 Jul 2026 02:23
- Source
- The Economic Times
Healthcare Stocks: J&J, UnitedHealth, Abbott Face Test on Sector’s 9% Earnings Drop
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 12 Jul 2026 21:01
- Source
- TechStock²
Abbott India Limited Actuals & Estimates (NSE:ABBOTINDIA)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 13:19
- Source
- TradingView
Abbott India Ltd gains for fifth session
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 06 Jul 2026 07:48
- Source
- Business Standard
Abbott India Ltd drops for fifth straight session
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jun 2026 07:00
- Source
- Business Standard
Abbott India appoints Swati Pathak as Associate Director - Operations
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 May 2026 07:00
- Source
- scanx.trade
Abbott India Standalone March 2026 Net Sales at Rs 1,709.51 crore, up 6.54% Y-o-Y
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 May 2026 07:00
- Source
- Moneycontrol.com
Abbott India clocks PAT of Rs 394.93 crore in March'26 quarter
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 12 May 2026 07:00
- Source
- Business Standard
Abbott is the most oversold healthcare stock as Q1 earnings roll on (XLV:NYSEARCA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 22 Apr 2026 07:00
- Source
- Seeking Alpha
Double Downgrade: Abbott India Share Price Target, Rating Slashed On Weak Growth Outlook
- Tone
- Negative 42/100
- Event
- Analyst action
- Published
- 15 Apr 2026 07:00
- Source
- NDTV Profit
Abbott India shares decline 0.73% amid volume surge
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Feb 2026 08:00
- Source
- Moneycontrol.com
Getting In Cheap On Abbott India Limited (NSE:ABBOTINDIA) Is Unlikely
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Jan 2026 08:00
- Source
- simplywall.st
Abbott India Ltd. Share Price Today - Abbott India Ltd. Stock Price Live NSE/BSE
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jan 2026 10:51
- Source
- CNBC TV18
Abbott India Limited (NSE:ABBOTINDIA) stock most popular amongst public companies who own 75%, while individual investors hold 17%
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Dec 2025 08:00
- Source
- simplywall.st
Abbott India Share Price Target 2026, 2027, 2030, 2040, 2050
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 11 Dec 2025 08:00
- Source
- shareprice-target.com
Abbott India Limited's (NSE:ABBOTINDIA) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 24 Nov 2025 08:00
- Source
- simplywall.st
abbott india reports strong q2fy26 performance with revenue growth improving ebitda and pat
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 07 Nov 2025 09:51
- Source
- ICICI Direct
Abbott India (NSE:ABBOTINDIA) shareholders have earned a 15% CAGR over the last five years
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Oct 2025 07:00
- Source
- simplywall.st
Abbott India's profit climbs on healthy pharmaceutical demand
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 12 Aug 2025 07:00
- Source
- Reuters
Abbott India (NSE:ABBOTINDIA) Will Pay A Larger Dividend Than Last Year At ₹475.00
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 22 Jul 2025 07:00
- Source
- simplywall.st
Abbot India signs non-exclusive patent license agreement to market Vonoprazan under the brand name Vonefi
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Sep 2024 07:06
- Source
- Upstox
Abbott India Q4 Results 2026 - Find Abbott India Q4 Earnings Result | ABBOTINDIA Q4 results
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 24 Jul 2023 10:34
- Source
- livemint.com
Abbott India Ltd (ABBOTINDIA) Share Price
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 31 Jan 2023 08:57
- Source
- Business Today
Abbott India Ltd. Share Price Today | Abbott India Live NSE/BSE
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Apr 2022 07:08
- Source
- Value Research
ABBOTT INDIA SHARE PRICE TODAY
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jan 2022 04:55
- Source
- ICICI Direct
Abbott India Share Price - Live NSE: ABBOTINDIA Stock Price & Chart
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Oct 2021 05:48
- Source
- Upstox